Fundraising FoxLino Biotech
1 known investors
Find your way into Lino Biotech
Sign up to see every warm intro you have to Lino Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lino Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lino Biotech develops the MACS Matchmaker, a label-free binding-analysis platform based on focal molography that measures antibody and drug-candidate kinetics directly in complex biological samples such as serum, lysate, and plasma. It serves biopharma and drug-discovery scientists with applications including polyreactivity screening, FcRn and Fc receptor profiling, plasma protein binding, DEL hit validation, and PROTAC ternary complex characterization.
Investors · 1
Frequently asked questions
- What does Lino Biotech do?
- Lino Biotech develops the MACS Matchmaker, a label-free binding-analysis platform based on focal molography that measures antibody and drug-candidate kinetics directly in complex biological samples such as serum, lysate, and plasma. It serves biopharma and drug-discovery scientists with applications including polyreactivity screening, FcRn and Fc receptor profiling, plasma protein binding, DEL hit validation, and PROTAC ternary complex characterization.
- Who are Lino Biotech's investors?
- Lino Biotech's investors include Roche Venture Fund.